Form 4: Oracle VP Sells Shares Under 10b5-1 Plan

Oracle's Vice Chairman, Jeffrey Henley, executed a series of stock option exercises and sales totaling over 745,000 shares under a pre-arranged Rule 10b5-1 trading plan.

Summary

• Jeffrey Henley, Vice Chairman and a director at Oracle Corp, reported transactions involving the exercise of stock options and subsequent sale of common stock.
• These transactions occurred on June 24, 2026, and were conducted under a Rule 10b5-1 trading plan adopted on January 2, 2026.
• Henley exercised options for 400,000 shares at a price of $40.93 per share.
• Following the exercise, a total of 745,000 shares were sold across multiple transactions at weighted average prices ranging from $155.50 to $165.57.
• The filing details the breakdown of these sales, with individual transaction prices and amounts.
• Following these transactions, Henley's direct beneficial ownership of Oracle common stock is 0 shares, but he retains indirect beneficial ownership of 745,000 shares through a GRAT, a Trust, and the Henley Community Property Trust.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing. While the sale of a large number of shares by a key executive can be a negative signal, the execution under a Rule 10b5-1 plan mitigates concerns about insider trading and suggests a pre-planned financial strategy.

Positives

• The transactions were executed under a Rule 10b5-1 plan, indicating a pre-determined and structured approach to stock sales, which can mitigate insider trading concerns.
• The exercise of stock options at $40.93 and sale at significantly higher prices ($155.50 - $165.57) demonstrates a substantial gain on the exercised options.

Negatives

• A significant reduction in direct beneficial ownership of Oracle common stock by a key executive and director.
• The sale of a large block of shares could be perceived negatively by the market, potentially impacting share price if not adequately contextualized.

Risks

• The sale of a substantial number of shares by a high-ranking executive could be interpreted as a lack of confidence in future stock performance, although executed under a 10b5-1 plan.
• The weighted average sale prices indicate a range of market conditions during the execution of the plan, with some sales occurring at lower prices within that range.

Future Outlook

The filing itself does not contain forward-looking statements or guidance from the company. It solely reports past transactions by an insider.

Management Comments

• The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Industry Context

StockSavvy.ai notes that Form 4 filings are routine for executives and directors, detailing changes in their beneficial ownership of company stock. The use of Rule 10b5-1 plans is a common strategy for insiders to diversify holdings or manage personal finances without triggering insider trading concerns, especially for large transactions.

Stakeholder Impact

• Shareholders: May perceive the sale of a large number of shares by a director and officer as a negative signal, potentially impacting short-term stock price, despite the Rule 10b5-1 plan.
• Employees: Similar to shareholders, employees holding stock options or company stock may view this as a sign of reduced confidence from management.

Key Dates

Recommendation

The filing reports a significant sale of stock by a key executive under a pre-arranged plan. While the sale itself can be a bearish signal, the use of a Rule 10b5-1 plan indicates a structured and compliant approach, reducing concerns about adverse insider knowledge. Without further context on Oracle's performance or the executive's personal financial needs, a 'hold' recommendation is prudent, acknowledging the potential for short-term price pressure while recognizing the compliant nature of the transaction.

Keywords

Oracle Corp, ORCL, Form 4, Insider Trading, Stock Options, Rule 10b5-1, Stock Sale, Beneficial Ownership, Jeffrey Henley, Executive Compensation